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In 2012 over 27 million Americans were suffering from Type II Diabetes 
(T2DM), which cost the U.S. $245 billion dollars in health care costs. Luckily, lifestyle 
changes and exercise can slow or prevent development of the disease. The purpose of our 
study was to determine the effect of high-intensity single-leg cycle training on insulin 
sensitivity and blood glucose levels in individuals with metabolic syndrome and insulin 
resistance, which put them at risk of developing T2DM. Seven individuals (age: 43 ± 14 
yrs, height: 165.0 ± 11.6 cm, weight: 103.6 ± 17.7, BMI: 38.1 ± 5.6 kg/m2) who 
displayed insulin resistance (CLIX-IR: 3.3 ± 1.2) and metabolic syndrome completed 12-
14 sessions of high-intensity, interval based, single-leg training (HIIT) at a minimal 
intensity of 80% of VO2PEAK power. Pre- and postoral glucose tolerance, blood lipid, and 
VO2PEAK tests were performed to determine the effect of training on insulin resistance, 
blood glucose levels, and additional health parameters. One-way repeated measure 
ANOVAs showed that single-leg training significantly improved HbA1c levels (5.8 ± 
0.5% pretraining vs. 5.6 ± 0.4% posttraining; p ≤ 0.05), and VO2PEAK capacity (1.4 ± 0.2 
L/min pretraining vs. 1.7 ± 0.3 L/min posttraining; p ≤ 0.05). Though not significant, 
single-leg training also increased mean insulin resistance scores (CLIX-IR) by ~ 40% 
(3.3 ± 1.2 vs. 4.7 ± 2.9; p = 0.15). Our study demonstrates that HIIT can drive significant 
improvement in clinically relevant health measures such as HbA1c and VO2PEAK capacity 
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in those at high risk for developing T2DM. Additionally, single-leg cycling is unique 
because it can minimize central hemodynamic stress (average heart-rate of 142 ± 15 
beats/min at ≥ 80% of VO2PEAK) while still providing adequate peripheral stimulus to 
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In 2012 more than 27 million Americans were suffering from Type II Diabetes 
(T2DM), which cost the U.S. $176 billion in direct health care costs, and $245 billion in 
total (Centers for Disease Control and Prevention, 2014). These costs result from the fact 
that diabetes is a burden to manage, and blood glucose levels need to be constantly 
monitored. Poorly controlled T2DM can result in severe health complications including 
vision loss, kidney failure, and lower limb amputation. Additionally, T2DM greatly 
increases the risk of heart disease and stroke, and individuals diagnosed with T2DM die 
from these diseases at a rate 2-4 times greater than nondiabetics (Centers for Disease 
Control and Prevention, 2011). Fortunately, lifestyle changes and exercise can improve 
the outlook for T2DM, and prevent those at risk of developing the disease from 
progressing.  In T2DM pathology, skeletal muscle insulin resistance is a key early defect 
that contributes to the development of the disease (Henriksen, Diamond-Stanic, & 
Marchionne, 2011). As a result, defects in skeletal muscle glucose utilization, and 




 The purpose of this study was to determine the effect of single-leg cycle training 




 Specifically, we investigated the effect of 6-weeks of high-intensity, interval 
based, single-leg cycle training on:  
1. Insulin sensitivity (CLIX-IR) 
2. Pancreatic beta-cell function (CLIX-Beta Cell) 
3. Blood glucose levels (fasting blood glucose and HbA1c)  




 In response to the stated research questions, we hypothesized that 6 weeks of 
high-intensity single-leg training would improve insulin sensitivity (CLIX-IR) and blood 

























REVIEW OF LITERATURE 
 
The GLUT-4 Transporter and T2DM 
 A key step in glucose utilization is the transport of glucose from the blood into the 
cells for energy production. Previous studies (Cline et al., 1999; Morino, Petersen, & 
Shulman, 2006; Shepherd & Kahn, 1999) have shown that insulin-stimulated glucose 
uptake into skeletal muscle via glucose tranporter-4 (GLUT4) proteins is the rate-limiting 
step of glucose metabolism in both healthy and diabetic populations. Decreased response 
to insulin-stimulated glucose transport in skeletal muscle is one major component that 
contributes to hyperglycemia and insulin resistance in T2DM (Cline et al., 1999; 
Henriksen, 2002; Shepherd & Kahn, 1999). The impairment of glucose uptake in T2DM 
is multifaceted with sites of dysfunction in the insulin signal cascade (Shepherd & Kahn, 
1999) as well as possible decreases in total GLUT4 density (Gaster et al., 2001). In 
several reports with human subjects, impaired insulin-stimulated glucose uptake seen in 
T2DM was not associated with decreased total muscle GLUT4 protein content (Schalin-
Jäntti et al., 1994), but rather reduced GLUT4 translocation to the cell surface (Ryder et 
al., 2000). In fact, Ryder and colleagues (2000) reported that basal levels of cell surface 
GLUT4 were similar between age, weight, and VO2 matched control and T2DM 
subjects, but administration of insulin had a blunted response in T2DM, resulting in 71% 
less insulin-stimulated cell surface GLUT-4. In contrast, other investigators report that 




in T2DM subjects (Gaster et al., 2001). More recently, Kampmann and colleagues (2011) 
reported that total GLUT4 expression was reduced by 30% in skeletal muscle from 
T2DM patients requiring insulin treatment when compared with either T2DM patients 
treated with oral anti-diabetics, or healthy controls. Furthermore, fasting plasma glucose 
and total GLUT4 density in slow-twitch muscle fibers were negatively correlated (r2 =      
-0.49) in T2DM (Gaster et al., 2001), suggesting a link between total GLUT4 content and 
hyperglycemia. Additionally, Doehner and researchers (2010) reported that lower 
GLUT4 protein content significantly predicted impaired insulin sensitivity in patients 
suffering from chronic heart failure. The defect in T2DM glucose transport is likely due 
to both decreased total GLUT4 density and impaired insulin signaling/GLUT4 
translocation. The end result remains decreased glucose clearance as demonstrated by 
Cline et al. (1999), who showed that T2DM patients displayed a rate of glucose uptake ~ 
80% lower than healthy controls when plasma concentrations of both insulin and glucose 
were held constant. As will be discussed, simple interventions such as exercise, aimed at 
improving GLUT4 density, translocation, and function, can be valuable in the treatment 
and prevention of T2DM. 
 
Mitochondrial Dysfunction and T2DM 
 Compounding the problem of decreased glucose uptake in T2DM is evidence that 
once glucose has entered the cell, mitochondrial function and substrate oxidation are also 
impaired. In support, Schrauwen-Hinderling and investigators (2007) used noninvasive 
magnetic resonance spectroscopy to show that in vivo muscle mitochondrial function was 
significantly decreased in T2DM. It is also generally accepted that skeletal muscle PGC-
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1α, a positive regulator of mitochondrial biogenesis and gene expression, is consistently 
down regulated in T2DM as well (Lira et al., 2010). Also, decreased mitochondrial-
biogenesis has been implicated in contributing to the pathogenesis of insulin resistance in 
skeletal muscle (Joseph et al., 2012). Patti (2004) reported that expression of both PGC-
1α and PGC-1β were reduced in Mexican American T2DM subjects by up to 46%. In 
support, Kelley and colleagues (2002) reported that total mitochondrial area was reduced 
by 35% in patients with T2DM, while Morino et al. (2005) reported that mitochondrial 
density was reduced by 38% in the insulin-resistant offspring of T2DM patients. 
Additionally, citrate synthase (CS), an enzyme used as a measure of mitochondrial 
activity, was reduced by ~35% in T2DM individuals (Kelley et al., 2002). More recently, 
Ritov and researchers (2010) reported that there was no significant difference in total 
mitochondrial content or CS activity between middle-aged, sedentary, lean subjects and 
T2DM individuals. The average activity of the electron transport chain (ETC), however, 
was significantly decreased by ~40% in the T2DM patients (Kelley et al., 2002; Ritov et 
al., 2010). Similarly, Petersen et al. (2004) showed a 30% decrease in rate of 
mitochondrial ATP production in young, lean, insulin-resistant children of T2DM parents 
when compared with age, weight, and activity matched insulin-sensitive controls. The 
fact remains that mitochondrial function is impaired in T2DM, and is likely due to 
decreased total mitochondrial density and impaired ETC capacity. Fortunately, as will 
again be demonstrated, exercise provides a potent positive stimulus to halt or reverse 





Exercise and T2DM 
 Exercise has been shown time and again to be an effective stimulus for improving 
glucose transport, mitochondrial biogenesis, and insulin sensitivity. Bruce and colleagues 
(2004) reported that 8-weeks (24 total sessions) of combined endurance and high-
intensity exercise training improved insulin sensitivity by ~30% in T2DM patients. 
Similarly, 10 to 12-weeks (48-60 total sessions) of endurance training improved oral 
glucose tolerance in insulin resistant subjects (Hughes et al., 1993) and whole body 
insulin-mediated glucose disposal in T2DM patients (Dela et al., 1995). Additionally, 2-
weeks (6 total sessions) of high intensity interval training (HIIT) improved insulin 
sensitivity by 35% in sedentary adults (Hood et al., 2011). In a review by Henriksen 
(2002), rat models indicated that the exercise-induced improvement in insulin action on 
skeletal muscle glucose uptake was associated with both increased GLUT4 density and 
adaptation of mitochondrial enzymes for glucose oxidation. In humans, 20 sessions of 
mixed endurance and intermittent high-intensity exercise increased skeletal muscle 
GLUT4 expression by 20% (Hussey et al., 2011). Similarly, 24 endurance-training 
sessions increased GLUT4 expression by 22% in T2DM patients and 38% in obese 
subjects (Christ-Roberts et al., 2004), while 48 exercise bouts increased GLUT4 by 60% 
(Hughes et al., 1993). Perhaps most surprisingly, two different studies utilizing 6 total 
sessions of HIIT increased total GLUT4 protein content by ~260% in sedentary adults 
(Hood et al., 2011) and ~369% in T2DM patients (Little et al., 2011), suggesting that 




 With respect to mitochondrial function, exercise has also been shown to increase 
PGC-1α, CS, and cytochrome c oxidase IV (COX-IV), a rate-limiting protein of the ETC 
and oxidative capacity. In T2DM subjects, 2-weeks (6 total sessions) of HIIT was 
sufficient to significantly improve skeletal muscle COX-IV protein levels (Little et al., 
2011), while 4-weeks (20 total sessions) of endurance training increased COX-IV 
expression by 49% (Hussey et al., 2011). Six sessions of HIIT in sedentary adults 
increased CS content by 31%, COX-IV content by 39%, and PGC-1α content by 56% 
(Hood et al, 2011), while 18 sessions of HIIT increased maximal activity of both COX-
IV and CS by ~50% in healthy females (Talanian et al, 2010). Improving both GLUT4 
function and mitochondrial health have implications in the treatment and prevention of 
insulin resistance and T2DM. Exercise is a proven stimulus to invoke these changes, but 
the most effective exercise modality remains unanswered (Little et al., 2011).  
 
Rationale for Single-Leg Cycling 
 Recently, Abbiss and colleagues (2011) reported that high-intensity single-leg 
cycle training significantly increased skeletal muscle GLUT4 and ETC enzyme content, 
when compared with more traditional double-leg training. In fact, single-leg cycling 
increased total GLUT4 content by ~100% when compared to traditional double-leg 
cycling. Similarly, single-leg training increased the ETC intermediates cytochrome 
oxidase II (COX II) by ~100%, and COX IV by ~200% (Abbiss et al., 2011). Even more 
impressive was that these results were seen after only 6 exercise bouts in a previously 
trained population where it had been expected that adaptations were already near 
maximum. Additionally, despite higher individual leg workloads achieved during single-
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leg cycling (198 W single-leg vs. 172 W double-leg), participants reported lower ratings 
of perceived exertion (RPE; 16 single-leg vs. 18 double-leg) and similar perceptions of 
quadriceps pain (Abbiss, 2011). Similarly, both average and peak heart rates were 
significantly lower during single-leg cycling (145 beats/min single-leg vs. 164 beats/min 
double-leg, and 168 beats/min single-leg vs. 180 beats/min double-leg; Abbiss, 2011). 
These results, respective to exercise exertion and single-leg cycling, provide a unique 
training paradigm for individuals with insulin resistance, metabolic syndrome, or T2DM. 
Many of these individuals lead a sedentary lifestyle and display a low VO2 capacity. 
Asking them to step into a rigorous, whole-body, large muscle-mass training regimen 
would prove difficult. Single-leg cycling presents a unique paradigm where a smaller 
muscle mass can be trained at relatively high intensity while not over-taxing the 
participant’s central hemodynamic capacity. Additionally, reports of lower RPE from 
single-leg training may improve exercise program adherence for previously sedentary 
individuals. We believe that if single-leg cycling can increase proteins and enzymes of 
glucose utilization (GLUT4, COX II and IV) so dramatically in elite athletes, then it may 
drive even larger adaptations in previously untrained, insulin resistant individuals, 




















 Individuals with insulin resistance and metabolic syndrome, but without frank 
T2DM or other complications were recruited for the current study. Prior to any study 
procedures, participants were informed about the protocols and potential risks both 
verbally and in writing. Informed written consent was obtained from all the participants 
prior to data collection. All study protocols were reviewed and were in accordance with 
the Institutional Review Boards of the University of Utah and Veterans Affairs Salt Lake 
City Health Care System. Volunteers who displayed a waist circumference of > 40 inches 
in men, or > 35 inches in women, were recruited from flyers placed at the University of 
Utah Hospital and School of Medicine. Initial screening for the presence of metabolic 
syndrome was conducted at PEAK Health and Fitness at the University of Utah. The 
presence of metabolic syndrome was confirmed if the volunteer met the previous criteria 
for waist circumference and displayed any two of the following measures: fasting blood 
glucose > 100 mg/dL, total fasting blood lipids > 150 mg/dL, HDL cholesterol < 50 
mg/dL in women or < 40 mg/dL in men, or blood pressure > 130/85 mm Hg. Upon 
confirmation of metabolic syndrome, participants received a secondary screening for 
insulin resistance at the University of Utah Center for Clinical and Translational Science 
(CCTS). To determine if volunteers were insulin resistant, a five-time-point oral glucose 





were monitored over the course of 2 hours. Severity of insulin resistance pre- and 
posttraining was determined using the Clamp Like Index Model (CLIX; Anderwald et al., 
2007). In humans, the severity of hyperglycemia is determined by a combination of 
pancreatic β-cell dysfunction and peripheral insulin resistance. CLIX is mathematical 
model that utilizes the five-time-point OGTT (0, 30, 60, 90, 120 minute) area under the 
curve (AUC) for plasma glucose and C-peptide levels to estimate peripheral insulin 
resistance (CLIX-IR) and pancreatic β-cell function (CLIX-Beta Cell; Anderwald et al., 
2007). Participants were considered insulin resistant if their CLIX-IR scores were < 6.0. 
Any participant whose OGTT indicated frank T2DM was referred directly to a physician 
for proper care. Additionally, any participant with symptoms of clinically relevant 
conditions that contraindicated intense exercise was also excluded.  
 
Design 
 A comparison of pre- and posttraining measures was used to determine the effect 
of a 6-week (12 session) exercise program on a number of health and metabolic 
parameters. Specifically, measures taken before and after high-intensity single-leg cycle 
training were used to assess changes in insulin resistance (CLIX-IR), pancreatic beta-cell 
function (CLIX-beta-cell), and blood glucose levels (fasting plasma glucose, HbA1c), as 
well as total blood lipids, HDL and LDL cholesterol, and VO2PEAK capacity.  
 
Oral Glucose Tolerance Test 
 Prior to training and again 14-48 hrs after their final exercise session, participants 
reported to the University of Utah CCTS for an OGTT. Participants reported to the CCTS 
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between 7:00 – 8:00AM following an overnight fast (12 hrs). Upon admittance an IV was 
placed into the individual’s antecubital vein, using an intracatheter needle (20–22 gauge). 
The intracatheter needle was kept patent between samples with a slow saline drip using 3-
way stopcock or saline flush after each blood draw. Baseline blood samples were drawn 
at the time of the IV placement. Following the draw of baseline samples, the patient was 
given a standard 75g glucose load. The entire solution was consumed within 5 minutes, 
and a timer was started at the “0 minute” when the patient finished their glucose drink. 
Subsequent blood samples were then drawn at the 30, 60, 90, and 120-minute time points. 
All samples were centrifuged on site, refrigerated, and then shipped overnight to Human 
Diagnostic Laboratories (Richmond, VA) to be analyzed for glucose, C-peptide, and 
insulin levels. Additionally, a comprehensive panel of baseline metabolic parameters 
were also measured and analyzed. 
 
Training 
 Prior to the training sessions, participants completed a single-leg VO2PEAK test 
to establish a baseline training intensity. Throughout the VO2PEAK test, gas exchange 
was assessed using indirect calorimetry on a TrueOne 2400 metabolic system (Parvo 
Medics, Sandy UT). Before each test, both the gas analyzer and ventilometer were 
calibrated. Participants were given 5 minutes of self-selected warm-up before beginning 
the VO2PEAK protocol. During the single-leg VO2PEAK test, participants began 
cycling at 20W, with power increasing 12.5W each minute thereafter. Termination of the 
protocol occurred when any two of the following criteria were met: the participant’s RER 
had risen above 1.1, they had reached their age predicted maximum HR, they reported a 
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rating of perceived exertion (RPE) (Borg’s 6-20 scale) of 19 or above, or they were 
unable to maintain a pedaling cadence of > 60rpm. VO2PEAK power was determined 
from the highest power stage completed in full. 
All participants then completed a minimum of 12 sessions of high-intensity 
single-leg cycle training over a period of ~40 days. All training was conducted on 
modified Monark cycle ergometers (HealthCare International Inc., Langley, WA) 
equipped with SRM Powermeters (SRM Service Center Inc., Colorado Springs, CO) 
under supervision at the Cardiac Rehabilitation Gym in the University of Utah Hospital. 
To preserve traditional cycling biomechanics during single-leg cycle training, a 
counterweight was fitted to the contra-lateral crank arm of each ergometer (Abbiss et al., 
2011; Thomas & Martin, 2009). 
 Each single-leg training session required the completion of three intervals, 4 
minutes in length, on each leg (24 total minutes of training). The 4 minute training 
intervals were separated by 6 minutes of active recovery. During all training intervals, 
participants were provided with continuous feedback of power output. Target training 
power was initially set at 80% of VO2PEAK power. Target training powers were then 
increased 4% per week for the following 5 weeks (Hickson, Bonzes, & Holloszy, 1977). 
This resulted in a total power increase of 20% over the course of the training regimen. 
Additionally, participants were encouraged to give their best effort, which in some cases 
exceeded the target power. The initial leg each participant used during single-leg cycling 
(right vs. left) was counterbalanced.  
 Heart rate (HR; Polar, Polar Electro Inc., Lake Success NY) was continuously 
recorded during all training sessions. Ratings of perceived exertion (RPE; Borg’s 6-20 
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scale) for the whole body and leg-only were recorded at the 4 minute mark of each 
interval. Total work completed during single-leg intervals was calculated using the 
following formula: work (J)= P Χ t, where P was the average power output (W) produced 
during the interval and t was the total time (s) performing intervals. Total work 
completed during single-leg cycling was calculated as the sum of the work from both 
right and left legs. 
 
Statistical Analyses 
 Separate one-way repeated measures ANOVAs (pretraining vs. posttraining) were 
used to determine if there were any changes in insulin resistance (CLIX-IR), pancreatic 
beta-cell function (CLIX-Beta cell), fasting blood glucose, HbA1c, VO2PEAK capacity, 
and blood lipids following training. Significance for all comparisons was set at P ≤ 0.05. 




























 Seven participants with insulin resistance and metabolic syndrome completed a 
minimum of 12 high-intensity single-leg training sessions. Physical and health 
characteristics are reported in Table 4.1. Three participants completed additional training 
sessions to accommodate posttest scheduling. Two participants completed 14 total 
training visits, while a third individual completed one extra training session, for a total of 
13. Average power output during all single-leg training intervals was 77 ± 13 W. During 
the 1st week of training, average power output was 65 ± 15 W, while average power 
output during the 6th week of training was 85 ± 12 W, resulting in a 31% (p ≤ 0.01) 
increase in training power. Average work completed over the entire training regimen was 
1405 ± 264 kJ. The average HR for all participants throughout training was 142 ± 15 
beats/min, while mean peak HR was 154 ± 17 beats/min. During the final 10 seconds of 
each interval, mean reported whole-body RPE was 15 ± 2, while RPE of the exercising 
leg was 17 ± 2. Training data are summarized in Table 4.2. 
 
Performance 
 Prior to training, absolute single-leg VO2PEAK capacity was 1.4 ± 0.2 L/min, 




increased by 19.5% (p ≤ 0.05) to 1.7 ± 0.3 L/min (Figure 4.1), while maximal aerobic 
power increased by 39% to 102 ± 20 W (p ≤ 0.01). 
 
Insulin Resistance and Glucose Control 
 Single-leg training significantly improved chronic blood glucose levels, assessed 
via HbA1c, from 5.8 ± 0.5% pretraining to 5.6 ± 0.4% posttraining (p ≤ 0.05; Figure 4.2). 
Though not statistically significant, mean CLIX-IR scores increased by 41% following 
training (3.3 ± 1.2 vs. 4.7 ± 2.9; p = 0.15), while pancreatic beta-cell function, estimated 
via CLIX-beta cell, increased by 59% (3.1 ± 1.3 vs. 4.9 ± 4.2; p = 0.25; Figure 4.3). 
Fasting insulin (18.9 ± 14.8 µU/mL pretraining vs. 23.1 ± 24.2 µU/mL posttraining; p = 
0.49), pancreatic C-peptide (3.6 ± 1.4 ng/mL pretraining vs. 3.5 ± 1.9 ng/mL posttraining; 
p = 0.74), and fasting plasma glucose levels (99.9 ± 20.4 mg/dL pretraining vs. 97.3 ± 
12.9 mg/dL posttraining; p = 0.48) were all unchanged following training. Finally, 
though again not significant, training decreased 2 hour OGTT blood glucose and insulin 
levels. Two-hour OGTT blood glucose decreased 23% (155 ± 48 mg/dL vs. 120 ± 27 
mg/dL; p = 0.16), while 2 hour insulin levels decreased 33% (111 ± 56 µU/mL vs. 74 ± 
58 µU/mL; p = 0.21; Figure 4.4). 
 
Health Parameters 
 Both weight (103.6 ± 17.7 kg pretraining vs. 104.1 ± 17.4 kg posttraining; p = 
0.45) and BMI (38 ± 6 kg/m2 pretraining vs. 38 ± 6 kg/m2 posttraining; p = 0.40) were 
unchanged following training. Because of incomplete lab reports, changes in blood lipid 
levels were assessed in 5 of the 7 participants. Training did not induce changes in the 
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concentration of high-density lipoprotein cholesterol (HDL; 54.2 ± 17.3 mg/dL 
pretraining vs. 52.4 ± 13.4 mg/dL posttraining; p = 0.64), low-density lipoprotein 
cholesterol (LDL; 42.2 ± 17.5 mg/dL pretraining vs. 42.6 ± 18.8 mg/dL posttraining; p = 
0.93), or total triglyceride levels (170.6 ± 79.0 mg/dL pretraining vs. 167.4 ± 64.8 mg/dL 






















Table 4.1:  
Clinical and anthropometric characteristics of all participants. 
 
 N = 7 
  
Age (yrs) 43 ± 14 
Height (cm) 165.0 ± 11.6 
Weight (kg) 103.6 ± 17.7 
BMI (kg/m2) 38.1 ± 5.6 
CLIX-IR 3.3 ± 1.2 
CLIX-Beta Cell 3.1 ± 1.3 
HbA1c (%) 5.8 ± 0.5 
Fasting Blood Glucose (mg/dL) 99.9 ± 20.4 
Total Triglycerides (mg/dL) 171.3 ± 70.6 
HDL-Cholesterol (mg/dL) 51.7 ± 16.7 
LDL-Cholesterol (mg/dL) 41.0 ± 15.9 
Single-leg VO2 Peak (L/min) 1.4 ± 0.2 
Relative VO2 Peak (mL/kg/min) 14.0 ± 3.8 
VO2 Peak Power (W) 73 ± 17 
  






Table 4.2:  














77 ± 13 142 ± 15 154 ± 17 15 ± 2 17 ± 2 1405 ± 264 






Figure 4.1: Training effects on VO2PEAK capacity. Training increased absolute single-leg 





























Figure 4.2: Training effects on HbA1c. Chronic blood glucose levels (HbA1c) were 
decreased 3.5% following training from prediabetic level (5.8 ± 0.5%) to within the 







































Figure 4.3: Training effects on CLIX-Indices. Though not statistically significant, insulin 
sensitivity (CLIX-IR) and pancreatic beta-cell function (CLIX-Beta Cell) were increased 
following training. Average CLIX-IR scores were increased by 41% (3.3 ± 1.2 vs. 4.7 ± 

































Figure 4.4: Two hour OGTT glucose and insulin. Though not statistically significant, 2 
hour OGTT blood glucose and insulin levels were decreased following training. Average 
2 hour blood glucose levels were decreased by 23% (155 ± 48 mg/dL vs. 120 ± 27 
mg/dL; p = 0.16), while 2 hour insulin levels were decreased by 33% (111 ± 56 µU/mL 












































DISCUSSION AND CONCLUSION 
 
 Our purpose was to investigate the effect of high-intensity, interval based, single-
leg training on insulin resistance, pancreatic beta-cell function, blood glucose levels, and 
exercise capacity in individuals with insulin resistance and metabolic syndrome. Our 
principal finding was that 12-14 sessions of single-leg HIIT significantly improved 
HbA1c, a clinically relevant measure of chronic blood glucose levels. The importance of 
HbA1c levels has been previously documented. Adams and colleagues (2009) reported 
that elevated HbA1c levels were significantly associated with the macrovascular diseases, 
cardiovascular disease (CVD), coronary heart disease (CHD), and stroke in nondiabetics. 
This relationship was established in both men and women after adjustment for factors 
including BMI and waist circumference (Adams et al., 2009). Similarly, Borg et al. 
(2011) showed that among an array of blood glucose indicators, HbA1c had the strongest 
association with CVD risk in individuals with T2DM. A review by Zanuso (2010) 
supports exercise as a way to decrease HbA1c and improve glucose control. Specifically, 
6 months of endurance exercise was shown to decrease average HbA1c levels by 4% in 
obese T2DM patients (Hansen, 2009). In our current study, we found that 12-14 sessions 
of single-leg cycling improved HbA1c levels by 3.5% (p ≤ 0.05) in obese insulin-
resistant individuals. Thus, our intervention elicited similar improvements to those shown 
by Hansen (2009), but in one-quarter the time. Additionally, our reported improvement 




the normal range. The finding that single-leg cycle training can improve HbA1c levels 
from the prediabetic range to normal is impressive, and strongly supports high-intensity, 
targeted training for those with chronically elevated blood glucose. Moreover, high-
intensity single-leg training elicited these changes rapidly thus minimizing exposure to 
the risks associated with elevated HbA1c. 
 In addition to improving chronic blood glucose levels, 6 weeks of single-leg 
training significantly improved cardio-respiratory fitness (CRF). This is also of great 
importance because of the effect aerobic capacity has on overall health. A study from the 
Aerobics Center Longitudinal Study (ACLS) compared all-cause and CVD mortality 
across fitness levels. When looking at the sexes independently, they found that the most 
fit men had a 43% lower risk for all-cause mortality and a 47% lower risk of CVD 
mortality, while the most fit women had 53% lower risk of all-cause mortality and 70% 
lower risk of CVD mortality (Lee et al., 2010). Similarly, in men with metabolic 
syndrome, those with the lowest CRF had a 2.25 greater risk of CVD mortality than those 
who were most fit (Katzmarzyk, Church, & Blair, 2004). A prospective study by Erikssen 
et al. (1998) followed ~2000 healthy men and reported that improvements in CRF over a 
7 year period were associated with a significantly lower risk of all-cause mortality for an 
additional 15 years of follow-up. Moreover, this protective effect was found to be 
independent of fitness level at baseline, or changes in body weight across the follow-up 
period (Erikssen, 1998). With respect to exercise, 48 sessions of aerobic training at 50% 
of maximal HR reserve increased aerobic capacity of double-leg cycling by 8.2% 
(Hughes et al., 1993). In comparison, Davies and Sargeant (1975) reported that 18 
sessions of single-leg exercise, 60 minutes in length, improved single-leg VO2PEAK 
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capacity by 14.0%, which corresponded to a 4.6% increase in double-leg VO2PEAK. In 
our study, 12-14 exercise sessions, incorporating only 24 minutes of high intensity 
exercise, improved single-leg VO2PEAK by 19.5%. This dramatic increase in CRF over 
a short time period provides further support that high-intensity, targeted training can 
improve overall health in those with insulin resistance, elevated blood glucose, and 
metabolic syndrome. The fact that improving aerobic capacity also decreases the risk of 
death from CVD is of utmost importance for individuals with elevated blood glucose 
levels, as these people are at higher risk for macrovascular diseases to begin with. 
 To assess insulin resistance we used the CLIX-IR model, which utilizes the 5-
time-point-OGTT AUC for plasma glucose and C-peptide levels to estimate glucose 
infusion rates (GIR; Anderwald et al., 2007). CLIX-IR was developed to accurately 
model the current “gold-standard” of measuring insulin sensitivity, the hyperinsulinemic 
clamp test, and is currently the most accurate way to assess insulin sensitivity from an 
easily performed OGTT. Improvements in insulin resistance following 6 weeks of single-
leg cycling were highly variable. Two of 7 participants showed no response, while the 
remaining 5 all improved, and in one instance, a ~112% increase in CLIX-IR was 
measured. In total, 6 weeks of single-leg training increased CLIX-IR scores by ~40%, 
although results were not statistically significant. Exercise is proven stimulus to improve 
insulin action, but the most effective training remains unproven. Forty-eight sessions of 
aerobic exercise was reported to improve insulin-stimulated glucose disposal (GIR) by 
11% (Hughes et al., 1993). More recently, both Hood et al. (2011) and Bruce and 
colleagues (2004) reported that 6-24 sessions of exercise incorporating HIIT was 
sufficient to improve insulin sensitivity by at least 30% in both sedentary adults and 
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T2DM patients. Again, while not statistically significant, our mean response to changes 
in insulin resistance were even greater than these, and when considered alongside the 
Hood (2011) and Bruce (2004) studies, HIIT training appears to be a very potent stimulus 
for improving insulin action.  
 Additionally, the single-leg cycling model is unique in that the exercising muscle 
can be worked at high intensity, >= 80% of VO2PEAK capacity, while central 
hemodynamic stress remains relatively low. Average heart rate for all participants during 
the 4 minute high-intensity single-leg intervals was 142 beats/min, while average ratings 
of perceived exertion, recorded using Borg’s 6-20 RPE scale, were 15 whole-body and 17 
for the exercising leg. Our average RPE values of 15 (defined as “hard”) and 17 (“very 
hard”) reinforce single-leg cycling’s ability to highly stress the exercising muscle while 
moderating central hemodynamic load. This is of great benefit to obese, insulin resistant, 
and prediabetic populations who likely have low CRF. In many cases, these individuals 
may be so limited by low aerobic capacity that traditional exercise would not allow them 
to work at a level sufficient to drive meaningful adaptation of exercising muscle. Four 
months of low intensity exercise, consisting of 150 minutes of brisk walking per week, 
did not change HbA1c levels or CRF in T2DM individuals (Fritz et al., 2006). Single-leg 
cycling is unique because it can provide a large stimulus to drive peripheral adaptation 
over a short time period (12-14 sessions), while simultaneously minimizing central 
hemodynamic stress and perceived effort to a level that allows previously sedentary 






 Limitations to the current study included difficulty locating and identifying 
qualified participants, resulting in a small cohort. An initial goal of our study design was 
to implement single-leg training in a drug naïve population. Finding study participants 
who exhibited insulin resistance, and subclinical hyperglycemia but who were not frank 
diabetic or on blood glucose medication proved difficult. A larger cohort size would have 
increased study power and helped definitively answer several of our research questions, 
specifically, what impact high-intensity single-leg training had on insulin resistance 
(CLIX-IR). Additionally, limited flexibility in exercise times was an issue. Safety 
concerns required that all exercise for the current study take place in a hospital setting. As 
a result, training availability was limited to twice a week, Tuesday and Thursday. This 
resulted in 4 off days between every second exercise session. Ideally, training would have 
taken place 3 days a week limiting the number of off-days to 2 in a row, and presumably 
increasing adaptive stimulus. 
 
Future Research 
 An important direction for future research is investigation into the effect of single-
leg training on individuals already diagnosed with frank T2DM. Preventing individuals at 
risk of developing diabetes from progressing is important, but equally relevant is 
improving the health of those who have already been diagnosed. It is known that exercise 
is important to those suffering from T2DM, but further investigation of high-intensity 
single-leg exercise is warranted. Additionally, combining targeted HIIT with other 




 Twelve to 14 sessions of high-intensity, interval-based, single-leg training 
significantly improved chronic blood glucose levels and CRF in obese individuals with 
insulin resistance, and metabolic syndrome. These findings provide evidence that 
targeted, high-intensity, small muscle mass exercise can be utilized to drive significant 
improvement in clinically relevant health measures, while simultaneously minimizing 
central hemodynamic stress, and levels of perceived exertion. This is of benefit when 
considering the safety of re-introducing sedentary individuals to exercise, while also 
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